Pages that link to "Q39499812"

The following pages link to Prevalence and patterns of the use of complementary therapies among prostate cancer patients: an epidemiological analysis (Q39499812):

Displaying 23 items.

• Selenium for alleviating the side effects of chemotherapy, radiotherapy and surgery in cancer patients (Q24245008) (← links)
• Complementary and alternative medicine: use and disclosure in radiation oncology community practice (Q30387278) (← links)
• Complementary and alternative medicine in prostate cancer (Q34328428) (← links)
• Selenium and Vitamin E for Prostate Cancer: Post-SELECT (Selenium and Vitamin E Cancer Prevention Trial) Status (Q34500651) (← links)
• Nutraceuticals and prostate cancer prevention: a current review. (Q34614720) (← links)
• Complementary and alternative medicine use among long-term lymphoma survivors: a pilot study (Q35160044) (← links)
• Prevalence and correlates of vitamin and supplement usage among men with a family history of prostate cancer. (Q35541832) (← links)
• Risk of prostate cancer in African-American men: Evidence of mixed effects of dietary quercetin by serum vitamin D status (Q35952018) (← links)
• Complementary and alternative medicines in prostate cancer: from bench to bedside? (Q36051522) (← links)
• Cancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: a systematic review. (Q36405687) (← links)
• Prostate cancer survival in Trinidad: Is PSA a prognostic factor? (Q36487174) (← links)
• Complementary and Alternative Medicine Use among Norwegian Cancer Survivors: Gender-Specific Prevalence and Associations for Use. (Q36763496) (← links)
• Chemoprevention of prostate cancer: lessons learned (Q36861734) (← links)
• Therapeutic applications of herbal medicines for cancer patients (Q37055147) (← links)
• Down-regulation of uPA and uPAR by 3,3'-diindolylmethane contributes to the inhibition of cell growth and migration of breast cancer cells (Q37132905) (← links)
• Inactivation of uPA and its receptor uPAR by 3,3'-diindolylmethane (DIM) leads to the inhibition of prostate cancer cell growth and migration (Q37335608) (← links)
• Fish-Derived Omega-3 Fatty Acids and Prostate Cancer: A Systematic Review (Q38882859) (← links)
• Use of alternative therapy in postmenopausal breast cancer patients treated with tamoxifen after surgery (Q45166105) (← links)
• Complementary therapies in cancer patients: prevalence and patients' motives (Q47348174) (← links)
• Use of complementary and alternative medicine by patients with urologic cancer: a prospective study at a single Japanese institution. (Q53294100) (← links)
• Complementary and alternative medicine use among men with prostate cancer in 4 ethnic populations (Q78304634) (← links)
• The use of dietary supplements in a community hospital comprehensive cancer center: implications for conventional cancer care (Q81692097) (← links)
• Use of Acupuncture Among Patients with Prostate Cancer Covered by National Health Insurance in Taiwan: A Retrospective Population-Based Study (Q93574382) (← links)